Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008
LONDON, September 6 /PRNewswire/ --
- Results Demonstrate Safety and Efficacy of First-in-Class Neurally Acting Anti-Migraine Agent (NAAMA) for the Treatment of Acute Migraine
CoLucid…